A single dose of attenuated vaccines could protect multiple sclerosis patients before starting immunosuppressive therapy
This strategy protects almost two thirds of patients. It also reduces the waiting time between vaccination and initiation of immune suppressive treatment. The study was carried out by René Carvajal, Mar Tintoré and Susana Otero-Romero, researchers at Cemcat, led by Xavier Montalbán, and the Vall d'Hebron University Hospital.